BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38402001)

  • 1. Left ventricular hypertrophy phenotype to predict incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.
    Wang L; Yi J; Zhou Z; Liu J; Li Y; Tian A; Ren X; Zheng X
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1399-1406. PubMed ID: 38402001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).
    Chrispin J; Jain A; Soliman EZ; Guallar E; Alonso A; Heckbert SR; Bluemke DA; Lima JA; Nazarian S
    J Am Coll Cardiol; 2014 May; 63(19):2007-13. PubMed ID: 24657688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
    Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic left ventricular hypertrophy predicts atrial fibrillation independent of left ventricular mass.
    Patel N; O'Neal WT; Whalen SP; Soliman EZ
    Ann Noninvasive Electrocardiol; 2017 May; 22(3):1-5. PubMed ID: 28019050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/ethnic differences in the prognostic utility of left ventricular mass index for incident cardiovascular disease.
    Akintoye E; Mahmoud K; Shokr M; Sandio A; Mallikethi-Reddy S; Sheikh M; Adegbala O; Egbe A; Briasoulis A; Afonso L
    Clin Cardiol; 2018 Apr; 41(4):502-509. PubMed ID: 29663526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in Left Atrioventricular Coupling Index to Predict Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Pezel T; Ambale-Venkatesh B; Quinaglia T; Heckbert SR; Kato Y; de Vasconcellos HD; Wu CO; Post WS; Henry P; Bluemke DA; Lima JAC
    Radiology; 2022 May; 303(2):317-326. PubMed ID: 35191736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of right atrial structure with incident atrial fibrillation: a longitudinal cohort cardiovascular magnetic resonance study from the Multi-Ethnic Study of Atherosclerosis (MESA).
    Xie E; Yu R; Ambale-Venkatesh B; Bakhshi H; Heckbert SR; Soliman EZ; Bluemke DA; Kawut SM; Wu CO; Nazarian S; Lima JAC
    J Cardiovasc Magn Reson; 2020 May; 22(1):36. PubMed ID: 32434529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation.
    Liang WY; Liu WW; Liu ML; Xiang W; Feng XR; Huang B; Chen XH; Sun YS
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):575-580. PubMed ID: 27162100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.
    Akkaya M; Higuchi K; Koopmann M; Burgon N; Erdogan E; Damal K; Kholmovski E; McGann C; Marrouche NF
    Europace; 2013 Dec; 15(12):1725-32. PubMed ID: 23711578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Magnetic Resonance-Measured Left Atrial Volume and Function and Incident Atrial Fibrillation: Results From MESA (Multi-Ethnic Study of Atherosclerosis).
    Habibi M; Samiei S; Ambale Venkatesh B; Opdahl A; Helle-Valle TM; Zareian M; Almeida AL; Choi EY; Wu C; Alonso A; Heckbert SR; Bluemke DA; Lima JA
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
    Okin PM; Wachtell K; Devereux RB; Harris KE; Jern S; Kjeldsen SE; Julius S; Lindholm LH; Nieminen MS; Edelman JM; Hille DA; Dahlöf B
    JAMA; 2006 Sep; 296(10):1242-8. PubMed ID: 16968848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in left atrial function predicts incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.
    Lim DJ; Ambale-Ventakesh B; Ostovaneh MR; Zghaib T; Ashikaga H; Wu C; Watson KE; Hughes T; Shea S; Heckbert SR; Bluemke DA; Post WS; Lima JAC
    Eur Heart J Cardiovasc Imaging; 2019 Sep; 20(9):979-987. PubMed ID: 31356656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA.
    Sparapani R; Dabbouseh NM; Gutterman D; Zhang J; Chen H; Bluemke DA; Lima JAC; Burke GL; Soliman EZ
    J Am Heart Assoc; 2019 Mar; 8(5):e009959. PubMed ID: 30827132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
    Erküner Ö; Dudink EAMP; Nieuwlaat R; Rienstra M; Van Gelder IC; Camm AJ; Capucci A; Breithardt G; LeHeuzey JY; Lip GYH; Crijns HJGM; Luermans JGLM
    Am J Cardiol; 2018 Aug; 122(4):578-583. PubMed ID: 29958714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Atrial Mechanical Function and Incident Ischemic Cerebrovascular Events Independent of AF: Insights From the MESA Study.
    Habibi M; Zareian M; Ambale Venkatesh B; Samiei S; Imai M; Wu C; Launer LJ; Shea S; Gottesman RF; Heckbert SR; Bluemke DA; Lima JAC
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2417-2427. PubMed ID: 31005519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic left ventricular hypertrophy predicts recurrence of atrial arrhythmias after catheter ablation of paroxysmal atrial fibrillation.
    Li SN; Wang L; Dong JZ; Yu RH; Long DY; Tang RB; Sang CH; Jiang CX; Liu N; Bai R; Du X; Ma CS
    Clin Cardiol; 2018 Jun; 41(6):797-802. PubMed ID: 29604089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the  RE - LY Trial.
    Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD; Connolly SJ; Yusuf S; Wallentin L
    J Am Heart Assoc; 2019 Jan; 8(2):e010107. PubMed ID: 30651032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of arterial stiffness with incident atrial fibrillation: a cohort study.
    Almuwaqqat Z; Claxton J'S; Norby FL; Lutsey PL; Wei J; Soliman EZ; Chen LY; Matsushita K; Heiss G; Alonso A
    BMC Cardiovasc Disord; 2021 May; 21(1):247. PubMed ID: 34016038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS).
    Mathew JS; Sachs MC; Katz R; Patton KK; Heckbert SR; Hoofnagle AN; Alonso A; Chonchol M; Deo R; Ix JH; Siscovick DS; Kestenbaum B; de Boer IH
    Circulation; 2014 Jul; 130(4):298-307. PubMed ID: 24920722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragmented sinoatrial dynamics in the prediction of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis.
    Costa MD; Redline S; Soliman EZ; Goldberger AL; Heckbert SR
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H256-H271. PubMed ID: 32986961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.